169174 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Pancreatic cells
METHODS FOR DIFFERENTIATION OF PANCREATIC EXOCRINE CELLS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS
#2MATERIALS AND METHODS FOR THE DELIVERY OF THERAPEUTIC NUCLEIC ACIDS TO TISSUES
#3ORGAN MODELS
#4Methods for generating stem cell-derived β cells and methods of use thereof
#5COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS
#6Diagnostic methods, therapeutic agents and uses thereof
#7Production and Enrichment of Pancreatic Endocrine Progenitor Cells
#8CELL-BASED ZNT8 ASSAY
#9METHODS OF CANCER IMMUNOTHERAPY
#10Materials and methods for the delivery of therapeutic nucleic acids to tissues
#11ApoCIII and the Treatment and Diagnosis of Diabetes
#12Flattop (fltp) is a novel biomarker for beta cell maturation
#13DIAGNOSTIC METHODS, THERAPEUTIC AGENTS AND USES THEREOF
#14Compositions and methods for identifying metabolically active agents
#15MUTANT MOUSE-DERIVED PANCREATIC ORGANOID AND USE THEREOF
#16IMMUNOPROTECTION OF PANCREATIC ISLETS
#17Methods for generating stem cell-derived beta cells and methods of use thereof
#18ORGAN MODELS
#19ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS
#20Use of aldehyde dehydrogenase as biomarker for beta-cell dysfunction and loss
#21Methods of differentiating stem cells by modulating MIR-124
#22THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#23STEM CELLS FOR MODELING TYPE 2 DIABETES
#24METHODS FOR GENERATING AUGMENTED STEM CELL-DERIVED BETA CELLS AND USES THEREOF
#25Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
#26INDIRECT ASSESSMENT OF INSULIN RELEASE IN A CELL
#27METABOLOMICS FOR DIAGNOSING PANCREATIC CANCER
#28ApoCIII and the Treatment and Diagnosis of Diabetes
#29THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#30Cartridge-based system for long term culture of cell clusters
#31Soluble MANF in pancreatic beta-cell disorders
#32COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS
#33SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT
#34Compositions and methods for reducing the risk of post-imaging pancreatitis
#35Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
#36PUMA, A PRO-APOPTOTIC GENE, AS A NOVEL MOLECULAR BIOMARKER FOR TNFALPHA-INDUCED HUMAN ISLET DAMAGE
#37COMPOSITIONS AND METHODS FOR DECREASING BLOOD GLUCAGON LEVELS
#38Methods and compositions to treat type-1 and type-2 diabetes
#39Methods for treating and/or limiting development of diabetes
#40Organoids for drug screening and personalized medicine
#41Method for detecting and purifying pancreatic beta cells
#42Use of SUSD2 protein as marker
#43Flattop (FLTP) is a novel biomarker for beta cell maturation
#44ApoIII and the treatment and diagnosis of diabetes
#45SCAFFOLDS FOR INHIBITORS OF MENIN-MLL INTERACTIONS
#46Method for inducing differentiation of insulin-producing cells
#47Methods of differentiating stem cells by modulating miR-124
#48METHOD OF DIFFERENTIATING MAMMALIAN PROGENITOR CELLS INTO INSULIN PRODUCING PANCREATIC ISLET CELLS
#49Medical use of artemisinin compounds and gephyrin agonists
#50Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
#51SCREENING ASSAY FOR AGENTS THAT INFLUENCE BETA CELL NUMBER AND/OR PHENOTYPE
#52Methods for treating and/or limiting development of diabetes
#53SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT
#54Stem cells for modeling type 2 diabetes
#55Methods for generating stem cell-derived beta cells and methods of use thereof
#56METHODS FOR GENERATING AUGMENTED STEM CELL-DERIVED BETA CELLS AND USES THEREOF
#57USE OF INSULIN SIGNALING ANTAGONISTS, OPTIONALLY IN COMBINATION OF TRANSFECTION OF NON-BETA CELLS, FOR INDUCING INSULIN PRODUCTION
#58ApoIII and the Treatment and Diagnosis of Diabetes
#59Methods for treating and/or limiting development of diabetes
#60CMPF as a biomarker for diabetes and associated methods
#61In vitro pancreatic differentiation of pluripotent mammalian cells
#62Soluble MANF in pancreatic β-cell disorders
#63Method for preparing endocrine aggregate of insulin-producing beta cells from human pluripotent stem cells
#64Method For Detecting And Purifying Pancreatic Beta Cells
#65Method of assessing pancreatic beta-cell function
#66MARKERS FOR FUNCTIONALLY MATURE BETA-CELLS AND METHODS OF USING THE SAME
#67Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
#68Methods of differentiating stem cells by modulating MIR-124
#69Methods for treating and/or limiting development of diabetes
#70ZSCAN4 as a marker for pancreatic stem cells and progenitor cells and use thereof
#71Methods for treating and/or limiting development of diabetes
#72Daikenchuto bioassay method and quality management method using same
#73Method of producing pancreatic hormone-producing cells
#74THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#75SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT
#76Method for obtaining pancreatic endocrine cells from adipose tissue-origin cells
#77Templated islet cells and small islet cell clusters for diabetes treatment
#78BETA-CELL REPLICATION PROMOTING COMPOUNDS AND METHODS OF THEIR USE
#79Method for manufacturing pancreatic-hormone-producing cells
#80Methods for treating and/or limiting development of diabetes
#81METHOD OF ASSESSING ISLET FUNCTION
#82Production of beta-cells
#83Methods For Identifying Compounds Effective To Increase The Expression Or Activity Of Aspartyl Aminopeptidase In Mammalian Pancreatic Islet Cells, And Methods For Decreasing Angiotensin II Levels In Mammalian Pancreatic Islet Cells
#84Method For Detecting And Purifying Pancreatic Beta Cells
#85METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS
#86PUMA, a pro-apoptotic gene, as a novel molecular biomarker for TNFα-induced human islet damage
#87CXCL4L1 AS A BIOMARKER OF PANCREATIC CANCER
#88Inositol Pyrophosphates Determine Exocytotic Capacity
#89INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#90CO-CULTURE COMPOSITIONS AND METHODS
#91Method for treating diabetes using neurturin
#92ApoIII and the treatment and diagnosis of diabetes
#93Inositol Pyrophosphates Determine Exocytotic Capacity
#94Potentiators of insulin secretion
#95Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
#96Methods for identifying compounds for the treatment of type 1 diabetes
#97Control of Exocrine Pancreatic Function Using Bone Morphogenetic Proteins
#98DDR1-mediated cell purification of pancreatic endocrine cells through their progenitors
#99Method for Obtaining Pancreatic Endocrine Cells From Adipose Tissue-Origin Cells
#100Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases
#101Drug screening using islet cells and islet cell progenitors from human embryonic stem cells
#102Method for screening compounds to determine those which enhance islet cell activity and/or survival and uses therefor
#103ENDOCRINE CELL LINES AND METHOD OF USING THE SAME
#104Methods using PBK1 for identifying agents that treat metabolic disorders
#105Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
#106Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
#107PANCREATIC ENDOCRINE PROGENITOR CELLS DERIVED FROM PLURIPOTENT STEM CELLS
#108Conditionally-Immortalised Pancreatic Cells
#109Transgenic pig with altered incretin function
#110Method for modulating insulin production
#111Islet Cells from Human Embryonic Stem Cells
#112Methods for identifying compounds for the treatment of type 1 diabetes
#113Inositol pyrophosphates determine exocytotic capacity
#114Methods for Identifying Compounds for the Treatment of Type 1 Diabetes
#115Methods of Modulating Beta Cell Function
#116Method for Preventing and Treating Diabetes Using Neurturin
#117Method For the Identification of Compounds Modulating Reverse Transport of Cholesterol
#118Islet Cells from Human Embryonic Stem Cells
#119Hes6 as a marker of pancreatic endocrine cells
#120Methods of screening for TRPM4 modulators of insulin secretion
#121Method for testing a compound for a therapeutic effect and a diagnostic method
#122Mptens as Modifiers of the Pten/Igf Pathway and Methods of Use
#123Ranbp2 as Modifiers of the Pten/Igf Pathway and Methods of Use
#124Method of Screening Antidiabetic Agents
#125Insulin-Independent, Bone Morphogenetic Protein (Bmp)-Mediated Uptake Of Blood Glucose By Peripheral Cells And Tissues
#126Methods For Diagnosing And Treating Endoplasmic Reticulum (er) Stress Diseases
#127Serum-free expansion of cells in culture
#128Method for preventing and treating diabetes using dg119
#129Endocrine cell lines and methods of using same
#130Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP
#131In vitro platform for screening agents inducing islet cell neogenesis
#132Methods for identifying compounds for treating diabetes mellitus
#133Inhibition of the β3 subunit of L-type Cachannels
#134Mechanism for identifying drugs for the treatment of type II diabetes
#135Methods of modulating β cell function
#136Method for screening compounds for those that modulate transducers of regulated CREB activity
#137CD39L3 and its role in diabetes
#138Method for screening substances capable of inhibiting the hyperplasia of pancreatic cells and/or the hypersecretion of insulin by pancreatic cells
#139Treatment for diabetes
#140Methods for identifying therapeutic targets involved in glucose and lipid metabolism
#141Cellular microarrays for screening differentiation factors
#142Method for screening substances capable of inhibiting the hyperplasia of pancreatic cells and/or the hypersecretion of insulin by pancreatic cells
#143Agents for proliferating pancreatic beta-cells of the islets of langerhans, agents for suppressing apoptosis of said cells, and screening of candidate compounds for these agents
#144Endoderm cells from human embryonic stem cells
#145Method and compositions for treating diseases targeting CD71
#146Methods for identifying compounds for treating diabetes mellitus
#147Lipin1 function
#148Methods of identifying insulin response modulators and uses therefor
#149Method of forming pancreatic beta cells from mesenchymal cells
#150Method of screening insulin content enhancer
#151Compositions and methods of using hexokinase V
#152Viral propagation system and uses thereof
#153Potentiators of insulin secretion
#154Method for differentiating stem cells into insulin-producing cells
#155Lactate dehydrogenase as a novel target and reagent for diabetes therapy
#156Cell-free assay for insulin signaling
#157Expression profile of pancreatic cancer